Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis. J of Skin [Internet]. 2022 Nov. 16 [cited 2025 Oct. 24];6(6):s74. Available from: https://skin.dermsquared.com/skin/article/view/1831